BKYI (BIO-key International) Forward Dividend Yield % : 0.00% (As of Jan. 18, 2025)

View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Forward Dividend Yield %?

As of today (2025-01-18), the Forward Annual Dividend Yield of BIO-key International is 0.00%.

As of today (2025-01-18), the Trailing Annual Dividend Yield of BIO-key International is 0.00%.

BKYI's Forward Dividend Yield % is not ranked ^*
in the Business Services industry.
Industry Median: 3.525
* Ranked among companies with meaningful Forward Dividend Yield % only.

BIO-key International's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of BIO-key International's Forward Dividend Yield %

For the Security & Protection Services subindustry, BIO-key International's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIO-key International's Forward Dividend Yield % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where BIO-key International's Forward Dividend Yield % falls into.

BIO-key International Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

BIO-key International (NAS:BKYI) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

BIO-key International Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of BIO-key International's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

BIO-key International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719

Website

https://www.bio-key.com

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Executives

Michael W Depasquale	director, officer: Co-Chief Executive Officer	1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan	officer: See Remarks	411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams	director	400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok	director	FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia	director	15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel	director	C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd	10 percent owner	5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin	director	FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis	director	3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao	director	SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush,	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch	officer: Chief Financial Officer	PO BOX 588, DUNSTABLE MA 01827
John Schoenherr	director	C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803